Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, October 4, 2022
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
[ Tue, Oct 04th 2022
] - WOPRAI
Mon, October 3, 2022
[ Mon, Oct 03rd 2022
] - WOPRAI
[ Mon, Oct 03rd 2022
] - WOPRAI
[ Mon, Oct 03rd 2022
] - WOPRAI
[ Mon, Oct 03rd 2022
] - WOPRAI
[ Mon, Oct 03rd 2022
] - WOPRAI
[ Mon, Oct 03rd 2022
] - WOPRAI
[ Mon, Oct 03rd 2022
] - WOPRAI
[ Mon, Oct 03rd 2022
] - WOPRAI
[ Mon, Oct 03rd 2022
] - WOPRAI
[ Mon, Oct 03rd 2022
] - WOPRAI
[ Mon, Oct 03rd 2022
] - WOPRAI
[ Mon, Oct 03rd 2022
] - WOPRAI
[ Mon, Oct 03rd 2022
] - WOPRAI
Neena Bitritto-Garg Maintained (AMLX) at Strong Buy with Increased Target to $50 on, Oct 3rd, 2022
Neena Bitritto-Garg of Citigroup, Maintained "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy with Increased Target from $48 to $50 on, Oct 3rd, 2022.
Neena has made no other calls on AMLX in the last 4 months.
There are 2 other peers that have a rating on AMLX. Out of the 2 peers that are also analyzing AMLX, 1 agrees with Neena's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $40 on, Friday, September 9th, 2022
This is the rating of the analyst that currently disagrees with Neena
- Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $50 on, Thursday, September 8th, 2022
